Earnings History Data for Jade Biosciences, Inc. (JBIO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Jade Biosciences, Inc.
Jade Biosciences Inc. is focused on developing therapies to address critical unmet needs in autoimmune diseases. The company pipeline includes antibody discovery programs, JADE-002 and JADE-003, currently in preclinical development. Jade Biosciences Inc., formerly known as Aerovate Therapeutics Inc., is based in WALTHAM, Mass.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
13-08-2025 | AH | JBIO | Jade Biosciences, Inc. | 6.00 | -0.86 | -0.43 | 0.00 | Jade Biosciences, Inc. GAAP EPS of -$0.86 [8/13/2025 5:10 PM] |
6.73 | -0.60 (-8.19%) |
7.33 | 0.0 (0.00%) |
6.13 - 13.50 | 50,191 | 100,000 | 1,345 | ||